Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients.Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants’ impact on protein structure and function.Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 ...
The widespread adoption of gene panel testing for cancer predisposition is leading to the identifica...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
BACKGROUND:The prevalence of BRCA1/2 variants in Chinese breast cancer patients varies among studies...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
BRCA1 and BRCA2 as important DNA repair genes have been thoroughly investigated in abundant studies....
Introduction:FANCC is reported as a novel susceptibility gene for breast cancer, however, its mutati...
Abstract Genetic testing for germline mutations in BRCA1/2 of patients with breast cancer (BC) is p...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Importance: Rare germline genetic variants in several genes are associated with increased breast can...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Introduction: Germline mutations of BRCA1 and BRCA2 account for the majority of hereditary breast ca...
The widespread adoption of gene panel testing for cancer predisposition is leading to the identifica...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
BACKGROUND:The prevalence of BRCA1/2 variants in Chinese breast cancer patients varies among studies...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset ...
BRCA1 and BRCA2 as important DNA repair genes have been thoroughly investigated in abundant studies....
Introduction:FANCC is reported as a novel susceptibility gene for breast cancer, however, its mutati...
Abstract Genetic testing for germline mutations in BRCA1/2 of patients with breast cancer (BC) is p...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Importance: Rare germline genetic variants in several genes are associated with increased breast can...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Purpose: The aim of this study is to further understand the status of BRCA1 and BRCA2 mutation among...
Introduction: Germline mutations of BRCA1 and BRCA2 account for the majority of hereditary breast ca...
The widespread adoption of gene panel testing for cancer predisposition is leading to the identifica...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
BACKGROUND:The prevalence of BRCA1/2 variants in Chinese breast cancer patients varies among studies...